{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:21Z","timestamp":1784751861757,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pbb.2024.173725","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:38:23Z","timestamp":1707439103000},"page":"173725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Preliminary investigation of the administration of biperiden to reduce relapses in individuals with cocaine\/crack user disorder: A randomized controlled clinical trial"],"prefix":"10.1016","volume":"237","author":[{"given":"Miguel Siqueira Campos","family":"Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9ia Gomes","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Fern\u00e1ndez","family":"Curado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Pauluci","family":"Greg\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos Fernandes","family":"Galdur\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pbb.2024.173725_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.addbeh.2013.10.019","article-title":"Prevalence of cocaine use in Brazil: data from the II Brazilian National Alcohol and Drugs Survey (BNADS)","volume":"39","author":"Abdalla","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pbb.2024.173725_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1016\/j.pbb.2024.173725_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pharmthera.2004.12.004","article-title":"Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement","volume":"106","author":"Anderson","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2024.173725_bb0020","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1111\/j.1447-0594.2010.00588.x","article-title":"Acetylcholine-dopamine balance hypothesis in the striatum: an update","volume":"10","author":"Aosaki","year":"2010","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.pbb.2024.173725_bb0025","first-page":"1466","article-title":"Biperiden challenge model in healthy elderly as proof-of-pharmacology tool: a randomized","volume":"61","author":"Bakker","year":"2021","journal-title":"Placebo-Controlled Trial. J Clin Pharmacol."},{"key":"10.1016\/j.pbb.2024.173725_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102278","article-title":"The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders","volume":"27","author":"Bakker","year":"2020","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.pbb.2024.173725_bb0035","doi-asserted-by":"crossref","unstructured":"Beck, A. T. (1961). An inventory for measuring depression. Archives of General Psychiatry 4(6): 561\u2013571.","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"10.1016\/j.pbb.2024.173725_bb0040","doi-asserted-by":"crossref","unstructured":"Beck, A. T., Epstein, N., Brown, G. and Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6): 893\u2013897.","DOI":"10.1037\/\/0022-006X.56.6.893"},{"key":"10.1016\/j.pbb.2024.173725_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.8049","article-title":"Comparison of treatments for cocaine use disorder among adults: a systematic review and meta-analysis","volume":"4","author":"Bentzley","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pbb.2024.173725_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbr.2017.05.031","article-title":"Role of acetylcholine and serotonin in novelty processing using an oddball paradigm","volume":"331","author":"Caldenhove","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.pbb.2024.173725_bb0055","first-page":"355","article-title":"Misuse of anticholinergic medications: a systematic review","volume":"10","author":"Chiappini","year":"2022","journal-title":"Biomedicine"},{"key":"10.1016\/j.pbb.2024.173725_bb0060","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/npp.2016.81","article-title":"Nucleus accumbens acetylcholine receptors modulate dopamine and motivation","volume":"41","author":"Collins","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173725_bb0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s13311-017-0525-z","article-title":"Reward circuitry in addiction","volume":"14","author":"Cooper","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.pbb.2024.173725_bb0070","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.euroneuro.2014.06.001","article-title":"Effects of biperiden on the treatment of cocaine\/crack addiction: a randomised, double-blind, placebo-controlled trial","volume":"24","author":"Dieckmann","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2024.173725_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108466","article-title":"Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics: a six-year cohort study using proportional hazards frailty models for recurrent treatment episodes","volume":"219","author":"Durand","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2024.173725_bb0080","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.neuropsychologia.2012.07.022","article-title":"A specific role for septohippocampal acetylcholine in memory?","volume":"50","author":"Easton","year":"2012","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.pbb.2024.173725_bb0085","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2362.1998.00393.x","article-title":"Scopolamine model of dementia: electroencephalogram findings and cognitive performance","volume":"28","author":"Ebert","year":"1998","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.pbb.2024.173725_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/1414-462x201700020268","article-title":"Evas\u00e3o do tratamento da depend\u00eancia de drogas: preval\u00eancia e fatores associados identificados a partir de um trabalho de Busca Ativa","volume":"25","author":"Fernandes","year":"2017","journal-title":"Cad. Saude Colet"},{"key":"10.1016\/j.pbb.2024.173725_bb0095","first-page":"8","article-title":"Factors that interfere in patient compliance with chemical dependence treatment: health professionals\u2019 perceptions","volume":"19","author":"Ferreira","year":"2015","journal-title":"REME"},{"key":"10.1016\/j.pbb.2024.173725_bb0100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0026-895X(25)09036-4","article-title":"Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors","volume":"41","author":"Flynn","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173725_bb0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0010-440X(91)90066-L","article-title":"The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale","volume":"32","author":"Halikas","year":"1991","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173725_bb0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0041-008X(60)90004-1","article-title":"Toxicologic studies on biperiden (Akineton) (1-bicycloheptenyl-1-phenyl-3-piperidinopropanol-1)","author":"Hanna","year":"1960","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173725_bb0120","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1073\/pnas.0631749100","article-title":"Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine","volume":"100","author":"Hikida","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2024.173725_bb0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.coph.2007.10.014","article-title":"Accumbens dopamine-acetylcholine balance in approach and avoidance","volume":"7","author":"Hoebel","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173725_bb0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002130000537","article-title":"Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice","volume":"152","author":"Itzhak","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2024.173725_bb0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbr.2010.11.033","article-title":"Acetylcholine and attention","volume":"221","author":"Klinkenberg","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173725_bb0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.physbeh.2011.04.052","article-title":"Cholinergic modulation of mesolimbic dopamine function and reward","volume":"104","author":"Mark","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2024.173725_bb0145","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1360-0443.1996.tb02324.x","article-title":"Section I. Theoretical perspectives on relapse: what is a relapse? Fifty ways to leave the wagon","volume":"91","author":"Miller","year":"1996","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pbb.2024.173725_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"10","author":"Moher","year":"2012","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.pbb.2024.173725_bb0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4603(90)90045-Y","article-title":"Integrating systemic cue exposure with standard treatment in recovering drug dependent patients","volume":"15","author":"O\u2019Brien","year":"1990","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pbb.2024.173725_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232086","article-title":"Retention of patients in opioid substitution treatment: a systematic review","volume":"15","author":"O\u2019Connor","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2024.173725_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbr.2012.03.030","article-title":"Biperiden (M\u2081 antagonist) impairs the expression of cocaine conditioned place preference but potentiates the expression of cocaine-induced behavioral sensitization","volume":"231","author":"Ramos","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173725_bb0170","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00213-014-3822-9","article-title":"Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram","volume":"232","author":"Sambeth","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2024.173725_bb0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-011-2225-4","article-title":"Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice","volume":"216","author":"Schmidt","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2024.173725_bb0180","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0306-4522(02)00665-6","article-title":"Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats","volume":"117","author":"See","year":"2003","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.pbb.2024.173725_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archpsyc.56.6.507","article-title":"A national evaluation of treatment outcomes for cocaine dependence","volume":"56","author":"Simpson","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173725_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0376-8716(96)01263-X","article-title":"The reliability of the Alcohol Timeline Followback when administered by telephone and by computer","volume":"42","author":"Sobell","year":"1996","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2024.173725_bb0195","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2165\/11310920-000000000-00000","article-title":"Cholinergic functioning in stimulant addiction: implications for medications development","volume":"23","author":"Sofuoglu","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2024.173725_bb0200","series-title":"The American Psychiatric Publishing Textbook of Psychopharmacology","first-page":"519","article-title":"Drugs to treat extrapyramidal side effects","author":"Stanilla","year":"2004"},{"key":"10.1016\/j.pbb.2024.173725_bb0205","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1523\/JNEUROSCI.2077-05.2005","article-title":"Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice","volume":"25","author":"Thomsen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173725_bb0210","unstructured":"UNOCD - United Nations Office on Drugs and Crime. 2023. Global Report on Cocaine Local Dynamics, Global Challenges. United Nations publications. Accessed on August 23, 2023."},{"key":"10.1016\/j.pbb.2024.173725_bb0215","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/sj.npp.1301585","article-title":"The role of acetylcholine in cocaine addiction","volume":"33","author":"Williams","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173725_bb0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2012.01.073","article-title":"Biperiden (an M1 antagonist) reduces memory consolidation of cocaine-conditioned place preference","volume":"513","author":"Zacarias","year":"2012","journal-title":"Neurosci. Lett."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:46:14Z","timestamp":1758775574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305724000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"alternative-id":["S0091305724000194"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173725","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary investigation of the administration of biperiden to reduce relapses in individuals with cocaine\/crack user disorder: A randomized controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173725"}}